Significantly higher mutation frequencies were noted in several cancer-associated genes, notably TP53, NOTCH, AKT, EGFR, MAP3K, and PIK3CA. Importantly the presence of mutations in NOTCH and PIK3CA, individually or in combination, was associated with worse outcomes (OS as well as PFS). The gene discussed is EGFR; the disease is cancer.